CloniBID FDA Approval Status
FDA Approved: No
Brand name: CloniBID
Generic name: clonidine hydrochloride
Company: Addrenex Pharmaceuticals, Inc.
Treatment for: High Blood Pressure
CloniBID is a 12-hour, sustained-release formulation of the centrally acting alpha-2 agonist clonidine hydrochloride under review for the treatment of hypertension.
Development timeline for CloniBID
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.